BI 695500 vs Rituxan First Line Treatment in Patients With Low Tumor Burden Follicular Lymphoma

Clinical trial NCT02417129 · TERMINATED

Trial details

NCT number: NCT02417129
Sponsor: Boehringer Ingelheim
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin

Start date: 2015-04-01
Primary completion: 2015-12-01
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.